Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Smoking Cessation and Nicotine De-addiction Products Market offers comprehensive insights into the ...

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRx™, today announced the ...

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure ...

The FDA also requested cytisinicline exposure data out to six months and one year to evaluate adequate longer-term safety risks, given that smoking cessation drugs are intended for chronic ...

New Directors Bring Extensive Leadership Experience in Corporate Strategy and Commercialization. SEATTLE and VANCOUVER, British Columbia, (GLOBE NEWSWIRE) -- Achieve ...

Achieve Life Sciences (ACHV) announced that its ongoing ORCA-OL clinical trial, designed to evaluate the long-term safety exposure of ...

Westmorland and Furness Council are appointing two new smoking cessation officers to provide support for residents seeking to quit smoking.